Skip to main content
. 2023 Jan 23;42(4):292–298. doi: 10.1097/INF.0000000000003832

FIGURE 1.

FIGURE 1.

Study disposition of all randomized participants. aRandomized participants who received any amount of study drug and have at least 1 acceptable causative uropathogen identified from a study-qualifying baseline urine culture. bAll randomized participants who received any amount of study treatment. C/T indicates ceftolozane/tazobactam; mMITT, microbiologic modified intent-to-treat.